Proteologics Inc.

Israeli start-up Pharma Two B has taken the concept of synergism seriously, from the eclectic group of scientists and managers it has brought together under one roof, to its fixed-dose combination str

Where potential approaches to drug discovery are concerned, ubiquitylation might not be the first word that springs to mind. But if recent developments are anything to go by, this biological process i

Merely judging from the activity at the early June ISLI Biomed Israel meeting, the industry’s annual gathering, Israeli biotech is hot. Exhibit booths—even of service providers—were crowded. Wherever